Suppr超能文献

头颈部癌症放疗对阻塞性睡眠呼吸暂停的影响:一项前瞻性研究。

Impact of radiotherapy for head and neck cancer on obstructive sleep apnea: a prospective study.

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, Juntendo University School of Medicine, Tokyo, Japan; Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan.

Department of Otorhinolaryngology, Head and Neck Surgery, Juntendo University School of Medicine, Tokyo, Japan.

出版信息

Ann Palliat Med. 2022 Aug;11(8):2631-2640. doi: 10.21037/apm-22-267. Epub 2022 Jun 21.

Abstract

BACKGROUND

In recent years, a relatively high prevalence of obstructive sleep apnea (OSA) in patients following radiotherapy (RT) for head and neck cancer (HNC) has been reported; however, little is known regarding the impact of RT on sleep disorders and the underlying mechanisms. This aim of this study was to elucidate the pathogenesis of OSA by comparing the clinical and sleep test parameters and magnetic resonance imaging (MRI) findings before and after HNC treatment with radiation.

METHODS

This prospective study included patients scheduled for RT with or without chemotherapy or bioradiotherapy for HNC. Patients diagnosed with HNC between May 2017 and August 2020 were consecutively recruited. The results of the sleep tests were analyzed both before and after treatment. The clinical characteristics of the patients and cephalometric and MRI parameters were also measured.

RESULTS

First, a total of 32 patients (64.8±11.8 years old; BMI, 22.7±3.6 kg/m2) underwent pre-treatment sleep tests. The prevalence of OSA [apnea hypopnea index (AHI) ≥5] in these patients was 81.3% (26 patients) before treatment, and the mean AHI was 20.8±19.0 events/hr. Next, 21 patients performed a sleep test both before and after treatment. Regarding subjective symptoms, there were no significant differences in the Epworth Sleepiness Scale (ESS) (P=0.142) or Pittsburgh Sleep Quality Index (PSQI) (P=0.935) after treatment; however, the BMI and neck circumference significantly decreased after treatment (P<0.0001 and P=0.0001, respectively). The incidence of OSA in these patients was 81.0% (17 patients) before treatment and 85.7% (19 patients) after treatment (P=1.0). Overall, the AHI was not significantly different, changing only from 14.5 to 14.9 after treatment (P=0.147). The MRI parameters showed that the retroglossal pharyngeal area increased significantly after treatment (P=0.007).

CONCLUSIONS

This study found that the prevalence of OSA before and after RT for HNC was higher than that in the normal population, despite a significant decrease in BMI and increase in the retroglossal pharyngeal area after treatment. We suggest that physicians who manage patients with HNC should consider the occurrence of OSA before and after treatment.

摘要

背景

近年来,有报道称头颈部癌症(HNC)放疗后患者阻塞性睡眠呼吸暂停(OSA)的患病率相对较高;然而,对于放疗对睡眠障碍的影响及其潜在机制知之甚少。本研究旨在通过比较 HNC 治疗前后的临床和睡眠测试参数以及磁共振成像(MRI)结果来阐明 OSA 的发病机制。

方法

这项前瞻性研究纳入了接受放疗(伴或不伴化疗或放化疗)治疗 HNC 的患者。2017 年 5 月至 2020 年 8 月连续招募了诊断为 HNC 的患者。分析了治疗前后的睡眠测试结果。还测量了患者的临床特征、头影测量学和 MRI 参数。

结果

首先,共有 32 名患者(64.8±11.8 岁;BMI,22.7±3.6 kg/m2)接受了治疗前的睡眠测试。这些患者在治疗前 OSA 的患病率[呼吸暂停低通气指数(AHI)≥5]为 81.3%(26 例),平均 AHI 为 20.8±19.0 次/小时。其次,21 名患者在治疗前后均进行了睡眠测试。就主观症状而言,治疗后 Epworth 嗜睡量表(ESS)(P=0.142)或匹兹堡睡眠质量指数(PSQI)(P=0.935)无显著差异;然而,BMI 和颈围在治疗后显著下降(P<0.0001 和 P=0.0001)。这些患者治疗前 OSA 的发生率为 81.0%(17 例),治疗后为 85.7%(19 例)(P=1.0)。总体而言,AHI 无显著差异,仅从治疗后 14.5 变为 14.9(P=0.147)。MRI 参数显示,治疗后会厌后咽部面积显著增大(P=0.007)。

结论

本研究发现,HNC 放疗前后 OSA 的患病率高于正常人群,尽管治疗后 BMI 显著下降,会厌后咽部面积增大。我们建议治疗 HNC 的医生应考虑治疗前后 OSA 的发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验